Oracle Hyperion是美国甲骨文(Oracle)公司的一套财务建模应用软件。该软件提供财务结算、报表制作等功能。 Oracle Hyperion 的 Oracle Hyperion Workspace product 存在安全漏洞,该漏洞源于 UI and Visualization 模块允许通过 HTTP 进行网络访问的低权限攻击者破坏 Oracle Hyperion Workspace。成功的攻击需要攻击者以外的人进行人际交互。 成功攻击此漏洞可能会导致对关键数据或所有 Oracle Hyp
Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.
| Vendor | Product | Affected Versions | CPE | Subscribe |
|---|---|---|---|---|
| Oracle Corporation | Hyperion BI+ | 11.2.13.0.000 | - |
|
| # | POC Description | Source Link | Shenlong Link |
|---|
No public POC found.
Login to generate AI POC| CVE-2023-21975 | 9.0 CRITICAL | Oracle Application Express 安全漏洞 |
| CVE-2023-21974 | 9.0 CRITICAL | Oracle Application Express 安全漏洞 |
| CVE-2023-22062 | 8.5 HIGH | Oracle Hyperion 安全漏洞 |
| CVE-2023-22014 | 8.4 HIGH | Oracle PeopleSoft Enterprise PeopleTools 安全漏洞 |
| CVE-2023-22018 | 8.1 HIGH | Oracle Virtualization 安全漏洞 |
| CVE-2023-22023 | 7.8 HIGH | Oracle Solaris 安全漏洞 |
| CVE-2023-22047 | 7.5 HIGH | Oracle PeopleSoft Enterprise PeopleTools 安全漏洞 |
| CVE-2023-22037 | 6.5 MEDIUM | Oracle E-Business Suite 安全漏洞 |
| CVE-2023-21994 | 6.5 MEDIUM | Oracle Fusion Middleware 安全漏洞 |
| CVE-2023-22040 | 6.5 MEDIUM | Oracle Fusion Middleware 安全漏洞 |
| CVE-2023-22022 | 6.5 MEDIUM | Oracle Health Sciences Applications 安全漏洞 |
| CVE-2023-22035 | 6.1 MEDIUM | Oracle E-Business Suite 跨站脚本漏洞 |
| CVE-2023-22055 | 6.1 MEDIUM | Oracle JD Edwards 安全漏洞 |
| CVE-2023-22042 | 6.1 MEDIUM | Oracle E-Business Suite 安全漏洞 |
| CVE-2023-21961 | 6.0 MEDIUM | Oracle Essbase 安全漏洞 |
| CVE-2023-22043 | 5.9 MEDIUM | Oracle Java SE 安全漏洞 |
| CVE-2023-22053 | 5.9 MEDIUM | Oracle MySQL 安全漏洞 |
| CVE-2023-21983 | 5.6 MEDIUM | Oracle Application Express 安全漏洞 |
| CVE-2023-22017 | 5.5 MEDIUM | Oracle Virtualization 安全漏洞 |
| CVE-2023-22011 | 5.4 MEDIUM | Oracle Business Intelligence Enterprise Edition 安全漏洞 |
Showing top 20 of 56 CVEs. View all on vendor page → →
No comments yet